论文部分内容阅读
目的观察阿维A联合潘生丁、西咪替丁治疗扁平疣的临床疗效及不良发应。方法选择2013年1月-2015年3月收治的扁平疣患者120例,随机分为观察组和对照组各60例,观察组予阿维A联合潘生丁、西咪替丁治疗;对照组予潘生丁口服及阿昔洛韦乳膏外用,观察、比较2组治疗效果及不良发应。结果观察组总有效率为96.67%明显高于对照组的73.33%,差异有统计学意义(P<0.05)。观察组总不良反应率为13.33%明显低于对照组的30.00%;差异有统计学意义(P<0.05)。结论阿维A联合潘生丁及西咪替丁治疗扁平疣,临床疗效明显,值得临床推广应用。
Objective To observe the clinical efficacy and adverse reactions of acitretin combined with dipyridamole and cimetidine in the treatment of flat warts. Methods 120 patients with flat warts who were admitted from January 2013 to March 2015 were randomly divided into observation group (60 cases) and control group (60 cases), observation group (treated with dipyridamole and dipyridamole) and cimetidine. The control group was treated with dipyridamole Oral and acyclovir cream for external use, observation, comparison of two groups of treatment and adverse reactions. Results The total effective rate was 96.67% in the observation group was significantly higher than 73.33% in the control group, the difference was statistically significant (P <0.05). The total adverse reaction rate in the observation group was 13.33%, which was significantly lower than that in the control group (30.00%). The difference was statistically significant (P <0.05). Conclusions Avi A combined with dipyridamole and cimetidine in the treatment of flat warts has obvious clinical curative effect and worthy of clinical application.